Search - tctmd.com

Displaying 521 - 540 of 2063

Sort: Relevancy | Date

Presentation TCT 2019

Switch Therapies/ USE NOACs Instead of Coumadin

Presenter: Dominick Angiolillo

September 27, 2019

Presentation TCT 2019

Drop ASA/ REDUCE Duration

Presenter: Roxana Mehran

September 27, 2019

Presentation TCT 2019

EVOLVE/ LEADERS Short DAPT Programs

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

COBRA REDUCE / MASTER DAPT

Presenter: Robert Byrne

September 27, 2019

Presentation TCT 2019

COMBO REDUCE

Presenter: Giuseppe De Luca

September 27, 2019

Presentation TCT 2019

XIENCE/ ONYX Short DAPT Programs

Presenter: Mitchell Krucoff

September 27, 2019

Presentation TCT 2019

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

Idenifying the High Bleeding Risk Patient: The ARC HBR Definitions

Presenter: Philip Urban

September 27, 2019

Presentation TCT 2019

Case Presentation: A Patient at High Bleeding Risk and CAD- Real Management Dilemmas

Presenter: Davide Cao, MD

September 27, 2019

Presentation TCT 2019

Welcome and Introductions

Presenter: Roxana Mehran

September 27, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Presentation TCT 2019

Case #3: Transcatheter Tricuspid Therapy for Severe TR

Presenter: Christine Chung

September 25, 2019

Presentation TCT 2019

Case #2: Mitral Valve-in-MAC

Presenter: Stephanie El-Hajj

September 25, 2019

Presentation TCT 2019

Case #1: Complex TAVR ⁠— Bioprosthetic Valve Failure

Presenter: Maureen McKiernan

September 25, 2019

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Todd Neale

September 11, 2019

Advertisement

Switch Therapies/ USE NOACs Instead of Coumadin

Drop ASA/ REDUCE Duration

EVOLVE/ LEADERS Short DAPT Programs

COBRA REDUCE / MASTER DAPT

COMBO REDUCE

XIENCE/ ONYX Short DAPT Programs

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Idenifying the High Bleeding Risk Patient: The ARC HBR Definitions

Case Presentation: A Patient at High Bleeding Risk and CAD- Real Management Dilemmas

Welcome and Introductions

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Case #3: Transcatheter Tricuspid Therapy for Severe TR

Case #2: Mitral Valve-in-MAC

Case #1: Complex TAVR ⁠— Bioprosthetic Valve Failure

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content